When you walk into a pet store, you are usually greeted by a wall of colorful kibble bags that all promise the same thing: a happy, healthy dog. Royal Canin has spent decades trying to slice through that noise by pushing the science angle. Their latest campaign, developed alongside 22feet Tribal, shifts focus from generic wellness to the hyper-specific nutritional needs of different breeds, ages, and lifestyles. It is a calculated move to remind pet owners that a Golden Retriever and a French Bulldog aren’t just different in shape—they are biological opposites when it comes to what should be in their food bowls.
The creative direction here leans heavily on the idea of ‘precise nutrition.’ Instead of the usual montage of puppies chasing balls in a park, the brand is pushing a narrative of expertise. 22feet Tribal has built out a strategy that treats the consumer as an informed partner. This is a smart pivot. The Indian pet care market has shifted rapidly from ‘feeding the dog leftovers’ to treating pets as family members who deserve premium care. Royal Canin is banking on the fact that once you buy into the science, you aren’t going to switch to a cheaper generic bag, even if the price tag is significantly higher.
However, there is a potential trap in this messaging. By positioning themselves as the brand for ‘precise’ science, Royal Canin is effectively distancing themselves from the casual buyer. They are chasing the high-intent pet parent—the kind of person who knows the specific protein-to-fat ratio their cat needs. While this builds deep brand loyalty, it does little to widen their base among the millions of new pet owners in India who are still navigating basic grooming and food choices. They are betting on depth of wallet rather than breadth of market reach.
The execution shows a clear understanding of the digital-first habits of modern Indian pet owners. Using data-driven touchpoints to meet pet parents where they are—likely scrolling for advice on why their dog is scratching or which kibble will stop shedding—is exactly where 22feet thrives. By linking the creative output to tangible health outcomes, they are essentially selling a solution to a problem, not just a product on a shelf. It is a classic move, but one that is becoming increasingly necessary as the Indian pet segment gets crowded with international entrants and local D2C upstarts.
Ultimately, this campaign isn’t about reinventing the wheel; it is about reinforcing an existing moat. Royal Canin knows that in the premium pet food business, once you convince an owner that their dog’s health is intrinsically tied to your specific ingredient list, you have a customer for life. Whether this high-brow, science-led approach translates to massive scale in a price-sensitive market like India remains the real question. For now, they are playing the long game, positioning themselves not as a snack provider, but as a silent partner in pet longevity.
